(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from INPI

FORMA CRISTALINA DE N-(2-CLORO-3-((5-CLORO-3-METIL-4-OXO-3,4-DI-HIDROQUINAZOLIN-6-IL)AMINO)-4-FLUOROFENIL)-3-FLUOROAZETIDINA-1-SULFONAMIDA

Em AnáliseInvention PatentPCT · IB2022061716

Application data

Number

112024010058

Type

Invention Patent

Filing

12/02/2022

Publication

08/27/2024

PCT

IB2022061716

Progress at the INPI

  1. Filing12/02/22
  2. Publication
  3. Examination
  4. Allowance
  5. Grant
  6. In force

The application was filed at the INPI on 12/02/2022. It awaits formal examination and publication in the RPI gazette.

Leave your contact and we will alert you

We track INPI publications and let you know as soon as this case moves.

We use your details only for this alert.

Latest action published by the INPI: 08/27/2024. We update with every new RPI gazette, published weekly.

Applicants and inventors

Applicants

ARRAY BIOPHARMA INC.

US

See this company's full portfolio

Inventors

C. C. (pessoa física)

US

Technical data

Priority claims

US

63/287,127 · 12/08/2021

US

63/393,043 · 07/28/2022

Abstract

FORMA CRISTALINA DE N-(2-CLORO-3-((5- CLORO-3-METIL-4-OXO-3,4-DI-HIDROQUINAZOLIN-6-IL)AMINO)-4- FLUOROFENIL)-3-FLUOROAZETIDINA-1-SULFONAMIDA. A presente invenção refere-se a uma forma cristalina de N-(2-cloro-3-((5-cloro-3-metil-4-oxo-3,4-di-hidroquinazolin-6-il)amino)-4-fluorofenil)-3-fluoroazetidina-1-sulfonamida, composições farmacêuticas compreendendo a referida forma cristalina, e métodos de uso da referida forma cristalina no tratamento de doenças e distúrbios associados à BRAF, tais como tumores associados à BRAF.

Prosecution history

Publications in the Brazilian Industrial Property Gazette (RPI).

Notificação de entrada na fase nacional - PCT

#1.3

08/27/2024

RPI 2799

Alteração de dados cadastrais

#1.1

05/28/2024

RPI 2786

Patent monitoring

Track this patent in real time.

Receive alerts on INPI events, decisions, and expiry dates for your portfolio.